Skip to main content
OpenTrials

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,935 public trials 1,510 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms trial results

Active, Not Recruiting

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

NCT02715284

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
View all 105 locations
View Trial Details
Active, Not Recruiting

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

NCT04468984

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Ironwood Cancer & Res Ctr /ID# 222162 Chandler, Arizona, United States
  • Highlands Oncology Group, PA /ID# 221826 Springdale, Arkansas, United States
  • City of Hope /ID# 218996 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 271382 Fullerton, California, United States
View all 229 locations
View Trial Details
Active, Not Recruiting

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

NCT02988960

Conditions
Advanced Solid Tumors Cancer, Bronchial Neoplasms, Carcinoma, +23 more
Locations
  • The Angeles Clinic and Researc /ID# 156324 Los Angeles, California, United States
  • The University of Chicago Medical Center /ID# 155264 Chicago, Illinois, United States
  • Massachusetts General Hospital /ID# 155267 Boston, Massachusetts, United States
  • Carolina BioOncology Institute /ID# 155265 Huntersville, North Carolina, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

NCT03843359

Conditions
Bites and Stings, Chemically-Induced Disorders, Neoplasms, +2 more
Locations
  • GSK Investigational Site Houston, Texas, United States
  • GSK Investigational Site Melbourne, Victoria, Australia
  • GSK Investigational Site Toronto, Ontario, Canada
  • GSK Investigational Site Bordeaux, France
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

NCT03899792

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Breast Diseases, +52 more
Locations
  • Childrens Hospital of Los Angeles Los Angeles, California, United States
  • The Children's Hospital for Cancer and Blood Disorders Aurora, Colorado, United States
  • Nemours Children's Health Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 26 locations
View Trial Details

Related conditions